UFC bantamweight Guido Cannetti failed a drug test last year due to a contaminated supplement, USADA announced Friday. He has been given a reduced, 10-month suspension and will be eligible to return by the end of this month.
Guido Cannetti has accepted a 10-month suspension from USADA.
USADA provisionally suspended Cannetti, a UFC bantamweight, last October after he was notified of a potential anti-doping violation. Almost a year later, USADA has confirmed that the positive drug test stemmed from a contaminated supplement. USADA announced the news in a press release Friday.
The out-of-competition drug test was administered by USADA on Oct. 5.
The Argentina native tested positive for ostarine, the stanozolol metabolites 16β-hydroxystanozolol and 4β-hydroxystanozolol, hydrochlorothiazide and chlorothiazide. “Ostarine and stanozolol are prohibited substances in the class of Anabolic Agents, while hydrochlorothiazide and chlorothiazide are prohibited substances in the class of Diuretics and Masking Agents,” the press release stated. All of the substances Cannetti tested positive for are prohibited under the UFC anti-doping policy at all times.
A World Anti-Doping Agency (WADA)-accredited laboratory in Salt Lake City, Utah, under the direction of USADA, tested opened and sealed containers of a supplement Cannetti declared he had been using. Both tests came back positive for all of the substances Cannetti tested positive for. None of the substances were listed on the product’s label.
Per the UFC anti-doping policy, if it is determined that a fighter failed a drug test due to a contaminated product, that fighter may receive a reduced suspension. In Cannetti’s case, he was given a 10-month sanction, lowered from the maximum two-year period of ineligibility.
Cannetti’s suspension began on Oct. 28, 2016, the date he was provisionally suspended. Cannetti, who was removed from last November’s UFC Fight Night 96 as a result of the positive drug test, will be eligible to return to action by the end of this month.